The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
about
Iron deficiency in patients with heart failurePatient selection in heart failure with preserved ejection fraction clinical trialsSoluble ST2 Testing: A Promising Biomarker in the Management of Heart FailureEpidemiology, diagnosis, and management of atrial fibrillation in womenPathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implicationsDiffering prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisHeart failure with preserved ejection fraction.Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.Maelstrom Research guidelines for rigorous retrospective data harmonizationPrognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort.Heart failure and preserved left ventricular function: long term clinical outcome.Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?Plasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection FractionCirculating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiologyComorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample.Heart failure: gaps in knowledge and failures in treatmentDesigning effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.Long-term survival for patients with acute decompensated heart failure according to ejection fraction findingsEvaluation of diastolic function by three-dimensional volume tracking of the mitral annulus with cardiovascular magnetic resonance: comparison with tissue Doppler imaging.Heart failure in elderly patients: distinctive features and unresolved issues.Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of AThe relationship between the severity of coronary artery disease and epicardial adipose tissue depends on the left ventricular function.Resistive and pulsatile arterial load as predictors of left ventricular mass and geometry: the multi-ethnic study of atherosclerosis.Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors.Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction.Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsMetabolomic fingerprint of heart failure with preserved ejection fraction.Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.Predictive value of brachial-ankle artery pulse wave velocity to heart failure with preserved ejection fraction in hospitalised patients with acute dyspnoea.Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry).Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa.Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort studyPredictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac deathMineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.
P2860
Q26822876-AA9E6A2E-DCB4-4F36-89CC-0B73FD08809EQ27015845-590EA4D7-B88A-4762-9A14-7C307278C90FQ28066438-5EE25811-BA3C-437B-A603-00D5DD7A74DDQ28083655-D98092FD-D1E4-4487-8287-1C80E144FC29Q28085102-CB8B7B77-8913-4494-9894-C2457139C01EQ28085643-155B82F5-2D77-4BE0-851B-49CB9EE69E25Q30420528-F1203570-8BEA-42BB-89E1-041C85D7D2A9Q30661992-1F42CEAB-31E3-4124-9187-E345945EF6ECQ30686199-2EE960F6-16F6-459D-9876-C200489106FAQ30847112-0196FB89-279F-466B-B4E5-5719B8DD35E8Q30952502-7B0DFA62-427C-410F-B60D-E00BDB1CCDBCQ31071475-72239ED1-765D-47A1-BFFA-306D102B8486Q31075676-B4ABB4F2-B528-4A6F-B9CF-168EC727F54AQ33164540-5C8590E9-F078-4D65-B656-C6A3D4C0156EQ33577412-70401ABF-76BE-4AFA-A7A3-B723D10B907AQ33711135-D503E9BD-F084-419E-AA72-997CC21D3D6BQ33748856-165FE553-F723-498C-97F5-3CAAED3F81E9Q33756448-320E443C-89C2-4CBD-906D-59B2A2998967Q34034800-7ADD5D20-62C9-422D-8E75-84A13F012591Q34162294-CDCAF9CB-8102-415A-B21D-457DE8F3E960Q34173702-CD247B05-73F5-45E4-9708-8E28B037E3B6Q34213824-505E6141-67A8-427D-940C-2D4E2BE91D93Q34248538-1E76FBDB-087C-4453-87F3-97EC094B9A4CQ34308075-1C356C68-E6AB-4DBC-A858-3DA8D32D53F9Q34375466-50450D46-AEF4-4F5B-BD9A-7DAA4CEE7F2CQ34431980-160E7A7F-A546-4548-BF09-2D700E69E100Q34469694-00A6A13C-0F97-44D5-8FBE-913F9840540DQ34714732-69708F44-843F-4135-959E-E30ADB02340DQ34821843-A6E4C212-B62F-44F9-8FC6-281C1E2FCA10Q35018132-ECADB278-33CC-454B-9B7D-683571BF0EF5Q35139959-763FE09B-D42C-4A09-8AD6-7DBB4188EB6AQ35641415-44CEDFB8-80A2-4654-90B7-539AC9F3E56CQ35792547-D99A3C74-BC45-4AAA-9648-383BCCC71E9FQ35796689-B55B906D-DD49-4632-B90C-9C9C08655C13Q36024237-0EAE662B-EC18-4024-BD6D-4BF2EBB5AF6DQ36029552-D11D430E-B481-4523-A04D-4862F7287539Q36141629-ABCA70FD-97D1-4CD2-9EC0-0340F2B8F61AQ36199988-37D16D74-458E-4351-BAFB-438493DCB10AQ36203696-41E1DF5D-0B78-4420-B811-458E99D1D41FQ36208986-B3338191-5F4D-4D9F-88D6-B29892BDCCF2
P2860
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The survival of patients with ...... al patient data meta-analysis.
@ast
The survival of patients with ...... al patient data meta-analysis.
@en
type
label
The survival of patients with ...... al patient data meta-analysis.
@ast
The survival of patients with ...... al patient data meta-analysis.
@en
prefLabel
The survival of patients with ...... al patient data meta-analysis.
@ast
The survival of patients with ...... al patient data meta-analysis.
@en
P2860
P921
P356
P1476
The survival of patients with ...... ual patient data meta-analysis
@en
P2093
Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
P2860
P304
P356
10.1093/EURHEARTJ/EHR254
P577
2011-08-06T00:00:00Z